Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysis

BACKGROUND: Human menopausal gonadotrophins and recombinant human follicle stimulating hormone are the two main gonadotrophin products utilized for controlled ovarian stimulation in assisted reproductive technologies. In this meta-analysis, the number of oocytes was designated as the most relevant e...

Descripción completa

Detalles Bibliográficos
Autores principales: Lehert, Philippe, Schertz, Joan C, Ezcurra, Diego
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954883/
https://www.ncbi.nlm.nih.gov/pubmed/20846363
http://dx.doi.org/10.1186/1477-7827-8-112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954883/
https://www.ncbi.nlm.nih.gov/pubmed/20846363
http://dx.doi.org/10.1186/1477-7827-8-112

Ejemplares similares